Myriad is a leading molecular
diagnostic company based in Salt Lake City, Utah.
ProAxsis is
a diagnostics company based in Northern Ireland, developing a range of products to identify active protease biomarkers of diseases.
Not exact matches
• Qvella, a Toronto -
based molecular
diagnostics company aiming to reduce the time to results in the diagnosis of infections, raised $ 20 million in series B funding.
• Parcom Capital acquired Viroclinics Biosciences, a Netherlands -
based diagnostic and clinical trial operation service
company.
• Epic Sciences, a San Diego, Calif. -
based diagnostics company, raised $ 40 million Series D funding.
The
Company also has a
diagnostic business
based on its DPNCheck ® product, which is a point - of - care test that provides accurate and cost - effective screening, diagnosis and monitoring of diabetic peripheral neuropathy (DPN).
About ChipCare ChipCare is a Toronto -
based company producing life - saving
diagnostics for infectious and non-communicable diseases in remote health settings with a mobile, simple - to - use & lab quality blood - testing platform.
Prior to joining Oberon, David was Chief Financial Officer and Treasurer at VolitionRx (NYSE MKT: VNRX), a multi-national medical
diagnostics company developing simple blood -
based tests to accurately diagnose a range of cancers.
Chicago -
based Hill - Rom Holdings Inc. bought 101 - year - old
company for $ 2.05 billion in September from the Allyn family and has continued to manufacture medical
diagnostic equipment under the Welch Allyn name in Skaneateles.
Researchers say the higher use of broad - spectrum antibiotics by the telemedicine doctors may be a result of direct - to - consumer
companies practicing conservatively,
based upon limited
diagnostic information about their patients.
The National University of Singapore (NUS) recently concluded a deal with Singapore -
based life science upstart Asia Pacific Genomics (AP Genomics), giving the
company exclusive rights to exploit its proprietary type - specific dengue fever
diagnostic primers.
To counter this, a «Free the Data» campaign has been launched by non-profit health advocacy group Genetic Alliance, the University of California, San Francisco, and San Francisco -
based genetic
diagnostics company InVitae.
«It's very surprising that the nematodes exhibited such a strong binary response to «cancer» versus «no cancer» urine,» says Michael Phillips at Menssana Research, a New Jersey -
based company developing
diagnostic tests
based on people's breath.
Since December 2010, WHO has endorsed the Xpert MTB / RIF test, a new molecular
diagnostic manufactured by Cepheid, a
company based in Sunnyvale, California.
The results are «very encouraging
diagnostic signals,» adds Pierre Rimbaud, chief medical officer at Enterome, a Paris -
based company that is developing microbiota -
based diagnostics.
Forward - looking statements include, but are not limited to: 1) the
companies plan to co-develop and commercialize DNA -
based diagnostic tests; 2) Illumina will gain access to disease - related biomarkers and deploy the markers into
diagnostic disease panels; 3) this alliance enables us to generate near - term product revenue.
Potential risks and uncertainties include, but are not limited to, the risks: a) deCODE's previously discovered at - risk variants may not be sufficiently informative to have
diagnostic value; b) Illumina's BeadLab infrastructure may not support sufficiently the high sample throughput envisioned by the parties; c) Illumina may not manufacture HumanHap BeadChips in adequate quantity or quality; d) the
companies may not see an increased customer
base as a result of the collaboration, as well as other risks and uncertainties detailed from time to time in deCODE's or Illumina's filings with the Securities and Exchange Commission.
The
companies will use the discovery as the
basis for further research and development in both
diagnostics and therapeutics.
May 15, 2006 deCODE and Illumina Form Alliance to Develop and Commercialize DNA -
based Diagnostics Companies to initiate work on molecular
diagnostics for the risk of heart attack, type 2 diabetes and breast cancer Illumina to install large - scale genotyping system and...
Esko is collaborating with Zacharon Pharmaceuticals, a San Diego -
based biotechnology
company, to develop a commercial
diagnostic assay for differentiating forms of MPS from urine and blood samples, a screening test for newborns and a tool for measuring the biochemical response of MPS patients to existing and novel therapies.
«High cholesterol has no symptoms, so many people don't know they're in trouble,» says Dr. Frank Cockerill, Chief Medical Officer at Chicago -
based Analyte Health — a
company that connects patients to
diagnostic services.
True Health Diagnostics — a Texas -
based laboratory
company that about two years ago acquired Health
Diagnostic Laboratory in downtown Richmond and now operates HDL's former headquarters — has started offering tests for hereditary cancers.
The
Company's technology allows for two - way communications with a vehicle which supports numerous applications including safety and security services, remote vehicle
diagnostics, remote emissions monitoring and other location -
based services.
In 2013, they added a UK -
based blood bank screening business & Immco
Diagnostics, a US (autoimmune)
diagnostics company.
Kenya -
based startup Nurse in Hand has signed a memorandum of understanding (MoU) with Apla Tech
Company to build a blockchain -
based mobile app that will store important patient data that will aid in the right
diagnostics of diseases.
[
company name], Inc., a member of the Roche Group, is a world leader and innovator of tissue -
based diagnostic solutions for patients worldwide.
Proficiently assisted dentist with
diagnostic, preventative, general, orthodontic, endodontic, surgical and periodontic procedures.Performed laboratory and radiologic support functions such as preparing materials and models.Expertly charted conditions of decay and disease to prepare for diagnosis and treatment by dentist.Administered local anesthetics and removed sutures and dressings.Gently and skillfully took and developed radiographs.Maintained proper graphical and perio charting.Consistently followed protocols regarding quality assurance, biohazards, infection control, charting and emergencies.Delivered preoperative and postoperative care.Greeted and prepared patients for dental examinations.Properly sterilized dental equipment and examination rooms in accordance with infection control policies.Coordinated appointment schedules for both the dentist and oral surgeon.Reviewed status of waiting room on a routine
basis to ensure that patients were being seen in a timely fashion.Correctly arranged instrument trays prior to dental procedures and surgeries.Duplicated x-rays when requested by insurance
companies.